Appropriate function of 11β-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase

被引:48
作者
Frick, C
Atanasov, AG
Arnold, P
Ozols, J
Odermatt, A
机构
[1] Univ Bern, Dept Clin Res, Div Nephrol & Hypertens, CH-3010 Bern, Switzerland
[2] Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06030 USA
关键词
D O I
10.1074/jbc.M313666200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By interconverting glucocorticoids, 11beta-hydroxysteroid dehydrogenase type 1 ( 11beta-HSD1) exerts an important pre-receptor function and is currently considered a promising therapeutic target. In addition, 11beta-HSD1 plays a potential role in 7-ketocholesterol metabolism. Here we investigated the role of the N-terminal region on enzymatic activity and addressed the relevance of 11beta-HSD1 orientation into the endoplasmic reticulum ( ER) lumen. Previous studies revealed that the luminal orientation of 11beta-HSD1 and 50-kDa esterase/ arylacetamide deacetylase (E3) is determined by their highly similar N-terminal transmembrane domains. Substitution of Lys(5) by Ser in 11beta-HSD1, but not of the analogous Lys(4) by Ile in E3, led to an inverted topology in the ER membrane, indicating the existence of a second topological determinant. Here we identified Glu(25)/Glu(26) in 11beta-HSD1 and Asp(25) in E3 as the second determinant for luminal orientation. Our results suggest that the exact location of specific residues rather than net charge distribution on either side of the helix is critical for membrane topology. Analysis of charged residues in the N-terminal domain revealed an essential role of Lys(35)/Lys(36) and Glu(25)/Glu(26) on enzymatic activity, suggesting that these residues are responsible for the observed stabilizing effect of the N-terminal membrane anchor on the catalytic domain of 11beta-HSD1. Moreover, activity measurements in intact cells expressing wildtype 11beta-HSD1, facing the ER lumen, or mutant K5S/ K6S, facing the cytoplasm, revealed that the luminal orientation is essential for efficient oxidation of cortisol. Furthermore, we demonstrate that 11beta-HSD1, but not mutant K5S/ K6S with cytoplasmic orientation, catalyzes the oxoreduction of 7-ketocholesterol. 11beta-HSD1 and E3 constructs with cytosolic orientation of their catalytic moiety should prove useful in future studies addressing the physiological function of these proteins.
引用
收藏
页码:31131 / 31138
页数:8
相关论文
共 45 条
[1]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains [J].
Alberts, P ;
Nilsson, C ;
Selén, G ;
Engblom, LOM ;
Edling, NHM ;
Norling, S ;
Klingström, G ;
Larsson, C ;
Forsgren, M ;
Ashkzari, M ;
Nilsson, CE ;
Fiedler, M ;
Bergqvist, E ;
Öhman, B ;
Björkstrand, E ;
Abrahmsén, LB .
ENDOCRINOLOGY, 2003, 144 (11) :4755-4762
[2]   Glutamate-115 renders specificity of human 11β-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+ [J].
Arnold, P ;
Tam, S ;
Yan, L ;
Baker, ME ;
Frey, FJ ;
Odermatt, A .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 201 (1-2) :177-187
[3]  
BANBEGYI G, 2004, J BIOL CHEM, V279, P27017
[4]   11β-hydroxysteroid dehydrogenase type 1:: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone [J].
Bannenberg, G ;
Martin, HJ ;
Bélai, I ;
Maser, E .
CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 143 :449-457
[5]   Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 [J].
Barf, T ;
Vallgårda, J ;
Emond, R ;
Häggström, C ;
Kurz, G ;
Nygren, A ;
Larwood, V ;
Mosialou, E ;
Axelsson, K ;
Olsson, R ;
Engblom, L ;
Edling, N ;
Rönquist-Nii, Y ;
Öhman, B ;
Alberts, P ;
Abrahmsén, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3813-3815
[6]   ATHEROSCLEROSIS AND STEROL 27-HYDROXYLASE - EVIDENCE FOR A ROLE OF THIS ENZYME IN ELIMINATION OF CHOLESTEROL FROM HUMAN MACROPHAGES [J].
BJORKHEM, I ;
ANDERSSON, O ;
DICZFALUSY, U ;
SEVASTIK, B ;
XIU, RJ ;
DUAN, CG ;
LUND, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8592-8596
[7]   Human 11β-hydroxysteroid dehydrogenase type 1 is enzymatically active in its nonglycosylated form [J].
Blum, A ;
Martin, HJ ;
Maser, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (02) :428-434
[8]   The critical role of the N-terminus of 11β-hydroxysteroid dehydrogenase type 1, as being encoded by exon 1, for enzyme stabilization and activity [J].
Blum, A ;
Maser, E .
CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 143 :469-480
[9]   Functional characterization of the human 11β-hydroxysteroid dehydrogenase 1B (11β-HSD 1B) variant [J].
Blum, A ;
Raum, A ;
Maser, E .
BIOCHEMISTRY, 2003, 42 (14) :4108-4117
[10]   Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism [J].
Brown, AJ ;
Sun, LP ;
Feramisco, JD ;
Brown, MS ;
Goldstein, JL .
MOLECULAR CELL, 2002, 10 (02) :237-245